Imerys S.A.
IMYSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $4 |
| % Growth | -5% | -11.4% | 16.8% | – |
| Cost of Goods Sold | $1 | $1 | $2 | $1 |
| Gross Profit | $2 | $2 | $3 | $2 |
| % Margin | 66.8% | 61.5% | 62.8% | 64.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $0 | $2 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $0 |
| Other Operating Expenses | $2 | $0 | $1 | $1 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 6.7% | 2.8% | 7.4% | 7.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -2.6% | 1.4% | 5.5% | 6.6% |
| EPS | -1.12 | 0.076 | 2.8 | 2.84 |
| % Growth | -1,579.5% | -97.3% | -1.4% | – |
| EPS Diluted | -1.12 | 0.6 | 2.76 | 2.79 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | -$0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $1 | $1 | $1 |
| % Margin | 9.4% | 13.2% | 14.6% | 16.7% |